|
Type:
|
Approved drug |
|
PubChem:
|
4173
|
|
DrugBank:
|
DB00916
|
|
IUPAC:
|
2-(2-methyl-5-nitro-1-imidazolyl)ethanol |
|
Standard InChI:
|
InChI=1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3 |
|
Standard InChIKey:
|
VAOCPAMSLUNLGC-UHFFFAOYSA-N |
|
SMILES:
|
CC1=NC=C([N+](=O)[O-])N1CCO |
|
Metabolism-related information:
|
Correlating the systemic availability of metronidazole with the retardation of drug release the reduced bioavailability of the drug from some oral sustained release formulations has been attributed to the metabolic activity of the intestinal microflora. Probably increase its liver toxicity
|
|
Reference:
|
10.1016/0378-5173(93)90121-U |
